Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.24B |
| 2 |
Apple
AAPL
|
+$939M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$714M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$673M |
| 5 |
Alibaba
BABA
|
+$591M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$1.45B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$653M |
| 3 |
GE Aerospace
GE
|
+$501M |
| 4 |
S&P Global
SPGI
|
+$439M |
| 5 |
SPDR Gold Trust
GLD
|
+$411M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.97% |
| 2 | Financials | 10.16% |
| 3 | Consumer Discretionary | 8.05% |
| 4 | Healthcare | 7.74% |
| 5 | Communication Services | 7.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ADAM
3876
Adamas Trust
ADAM
$919M
| $2.24M | ﹤0.01% |
90,693
+21,638
| +31% | +$544K |
|
|
INOV
3877
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $2.24M | ﹤0.01% |
149,192
+20,742
| +16% | +$330K |
|
|
IXYS
3878
DELISTED
IXYS Corp
IXYS
| $2.23M | ﹤0.01% |
93,253
-37,340
| -29% | -$900K |
|
|
ARAV
3879
DELISTED
Aravive, Inc. Common Stock
ARAV
| $2.23M | ﹤0.01% |
169,095
+161,329
| +2,077% | +$2.08M |
|
|
AUO
3880
DELISTED
AU Optronics Corp
AUO
| $2.23M | ﹤0.01% |
536,375
+519,878
| +3,151% | +$2.16M |
|
|
KE
3881
Kimball Electronics
KE
$607M
| $2.22M | ﹤0.01% |
121,655
+21,862
| +22% | +$451K |
|
3882
PTC Therapeutics
PTCT
$6.15B
| $2.22M | ﹤0.01% |
133,047
+29,357
| +28% | +$497K |
|
|
ENZY
3883
DELISTED
Enzymotec Ltd
ENZY
| $2.22M | ﹤0.01% |
+187,170
| New | +$2.17M |
|
3884
State Street SPDR S&P Global Infrastructure ETF
GII
$932M
| $2.22M | ﹤0.01% |
42,793
-14,328
| -25% | -$750K |
|
3885
AngioDynamics
ANGO
$651M
| $2.21M | ﹤0.01% |
133,148
+67,289
| +102% | +$1.15M |
|
|
FFIC
3886
DELISTED
Flushing Financial
FFIC
| $2.21M | ﹤0.01% |
80,217
+13,228
| +20% | +$381K |
|
|
IBDB
3887
DELISTED
iShares iBonds Mar 2018 Term Corporate ETF
IBDB
| $2.2M | ﹤0.01% |
86,150
+6,363
| +8% | +$163K |
|
3888
Nicolet Bankshares
NIC
$3.72B
| $2.2M | ﹤0.01% |
40,215
+1,878
| +5% | +$108K |
|
|
CSRA
3889
DELISTED
CSRA Inc.
CSRA
| $2.19M | ﹤0.01% |
73,182
-17,137
| -19% | -$518K |
|
|
HIX
3890
Western Asset High Income Fund II
HIX
$355M
| $2.19M | ﹤0.01% |
313,667
-273,461
| -47% | -$1.93M |
|
3891
VanEck IG Floating Rate ETF
FLTR
$3.04B
| $2.19M | ﹤0.01% |
86,513
+7,057
| +9% | +$178K |
|
|
MYOK
3892
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $2.19M | ﹤0.01% |
51,926
+23,923
| +85% | +$922K |
|
3893
Enova International
ENVA
$6.4B
| $2.19M | ﹤0.01% |
143,812
-82,895
| -37% | -$1.22M |
|
3894
Ingersoll Rand
IR
$33B
| $2.19M | ﹤0.01% |
64,416
+60,648
| +1,610% | +$1.81M |
|
|
FCRD
3895
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
| $2.19M | ﹤0.01% |
241,353
-114,272
| -32% | -$1.06M |
|
|
AVTA
3896
DELISTED
Avantax, Inc. Common Stock
AVTA
| $2.18M | ﹤0.01% |
98,775
-280,439
| -74% | -$6.25M |
|
3897
ARK Genomic Revolution ETF
ARKG
$1.79B
| $2.18M | ﹤0.01% |
89,083
+55,586
| +166% | +$1.41M |
|
|
INWK
3898
DELISTED
InnerWorkings, Inc.
INWK
| $2.17M | ﹤0.01% |
216,847
+43,106
| +25% | +$463K |
|
3899
Century Casinos
CNTY
$34.3M
| $2.17M | ﹤0.01% |
238,210
+26,698
| +13% | +$232K |
|
|
VTLE
3900
DELISTED
Vital Energy
VTLE
| $2.17M | ﹤0.01% |
10,219
+6,087
| +147% | +$1.34M |
|
Similar funds
Morgan Stanley's Q4 2017 Portfolio in Review
As of Q4 2017, Morgan Stanley held 6,934 positions worth $365B, up 9.4% from $334B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Morgan Stanley deployed $13.3B of net new capital in Q4 2017, opening 268 new positions and adding to 3,628 existing holdings. Its largest new stake was Highland Opportunities and Income Fund: 7,527,774 shares worth $117M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $1.45B trimmed.
- Morgan Stanley's largest Q4 2017 buy was Highland Opportunities and Income Fund: 7,527,774 shares worth $117M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $4.24B increase.
- Morgan Stanley's biggest Q4 2017 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $1.45B.
- Morgan Stanley fully exited Level 3 Communications Inc in Q4 2017, selling an estimated $210M.
- Morgan Stanley's ten largest holdings make up 14% of its $365B portfolio in Q4 2017.
- Morgan Stanley opened 268 new positions and closed 177 in Q4 2017.
- Morgan Stanley's portfolio value rose 9.4% quarter-over-quarter to $365B.
Based on Morgan Stanley's 13F filing for Q4 2017, filed 14 Feb 2018.